IMC Chicago
ROIV icon

IMC Chicago’s Roivant Sciences ROIV Stock Holding History

IMC Chicago’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.01M Sell
27,500
-75,100
-73% -$2.72M ﹤0.01% 3896
2026
Q2 		$3.63M Buy
102,600
+78,900
+333% +$2.33M ﹤0.01% 2435
2026
Q1 		$656K Sell
23,700
-419,800
-95% -$10.8M ﹤0.01% 3736
2025
Q4 		$9.6M Sell
443,500
-1,900
-0.4% -$37.5K ﹤0.01% 1251
2025
Q3 		$6.74M Buy
+445,400
New +$5.51M ﹤0.01% 1375

Other funds holding ROIV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return
Penn Davis McFarland
Penn Davis McFarland Dallas, Texas $1.17B AUM 26.22% 1-Year Est. Return

IMC Chicago's ROIV Position: Q3 2026 in Review

IMC Chicago increased its Roivant Sciences (ROIV) stake by 14% in Q3 2026, buying an estimated $346K and bringing the position to 78,171 shares worth $2.86M. The position accounts for ﹤0.01% of the portfolio, ranked #2790.

IMC Chicago first reported a position in ROIV in Q1 2026 and has held it in 3 quarters since. 234 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • IMC Chicago held 78,171 shares of Roivant Sciences worth $2.86M as of Q3 2026.
  • IMC Chicago bought 9,541 Roivant Sciences shares in Q3 2026, an estimated $346K.
  • Roivant Sciences made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #2790 holding.
  • IMC Chicago first reported a position in Roivant Sciences in Q1 2026 and has held it in 3 quarters since.
  • 234 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.